Recent advances in protection against doxorubicin-induced toxicity (Q37338134)

19 August 2017

title

Recent advances in protection against doxorubicin-induced toxicity (English)

1 reference

19 August 2017

R Injac

1

1 reference

19 August 2017

B Strukelj

series ordinal

2

1 reference

19 August 2017

publication date

1 December 2008

1 reference

Technology in Cancer Research and Treatment

19 August 2017

published in

1 reference

19 August 2017

volume

7

1 reference

19 August 2017

issue

6

1 reference

19 August 2017

page(s)

497-516

1 reference

Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Adriamycin-induced oxidative mitochondrial cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Anticancer agents and cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Pulmonary toxicity of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Gene electrotransfer into murine skeletal muscle: a systematic analysis of parameters for long-term gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Editorial: targeted drug delivery for cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Antioxidant nutrients and adriamycin toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Therapeutic and diagnostic applications of dendrimers for cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Polymeric micelles in oral chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Chemotherapy induced diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Doxorubicin toxicity in the Iron Age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

In vitro modeling of the structure-activity determinants of anthracycline cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Pulmonary toxicity of doxorubicin administered by in situ isolated lung perfusion in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Renal toxicities of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Protective effect of Lycium barbarum on doxorubicin-induced cardiotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Protective effect of selected flavonoids on in vitro daunorubicin-induced cardiotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Chronic supplementation of creatine and vitamins C and E increases survival and improves biochemical parameters after Doxorubicin treatment in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Effects of melatonin in reducing the toxic effects of doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Protectors against doxorubicin-induced cardiotoxicity: flavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Protection by flavonoids against anthracycline cardiotoxicity: from chemistry to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Protection of multiple antioxidants Chinese herbal medicine on the oxidative stress induced by adriamycin chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Schisandra fructus extract ameliorates doxorubicin-induce cytotoxicity in cardiomyocytes: altered gene expression for detoxification enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Protective effects of naringenin-7-O-glucoside on doxorubicin-induced apoptosis in H9C2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Salvianolic acids prevent acute doxorubicin cardiotoxicity in mice through suppression of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Inhibitory effects of water extract of propolis on doxorubicin-induced somatic mutation and recombination in Drosophila melanogaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Cytoprotective effect of anthocyanins against doxorubicin-induced toxicity in H9c2 cardiomyocytes in relation to their antioxidant activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Schisandrin B enhances doxorubicin-induced apoptosis of cancer cells but not normal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Synthesis and protective effects of coumarin derivatives against oxidative stress induced by doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Doxorubicin as an antioxidant: maintenance of myocardial levels of lycopene under doxorubicin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Protective effect of saponins from Panax notoginseng against doxorubicin-induced cardiotoxicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Protective effects of Terminalia arjuna against Doxorubicin-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Resveratrol in cardioprotection: a therapeutic promise of alternative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Potential hepatoprotective effects of fullerenol C60(OH)24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Cardioprotective effects of fullerenol C(60)(Oh)(24) on a single dose doxorubicin-induced cardiotoxicity in rats with malignant neoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Different effectiveness of piperidine nitroxides against oxidative stress induced by doxorubicin and hydrogen peroxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Differential effects of dihydropyridine calcium antagonists on doxorubicin-induced nephrotoxicity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

The use of dexrazoxane for the prevention of anthracycline extravasation injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Experimental study of dexrazoxane-anthracycline combinations using the model of isolated perfused rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Morphine is protective against doxorubicin-induced cardiotoxicity in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Erythropoietin protects cardiac myocytes against anthracycline-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Effects of doxorubicin-containing chemotherapy and a combination with L-carnitine on oxidative metabolism in patients with non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Preventive cardioprotection of erythropoietin against doxorubicin-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Late anthracycline cardiotoxicity protection by dexrazoxane (ICRF-187) in pediatric patients: echocardiographic follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Exercise training attenuates acute doxorubicin-induced cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Low-intensity exercise training during doxorubicin treatment protects against cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Mechanism of protection of moderately diet restricted rats against doxorubicin-induced acute cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Recent advances in nanooncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Vascular targeting of doxorubicin using cationic liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

In vivo distribution and antitumor activity of heparin-stabilized doxorubicin-loaded liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Characterization and cytotoxicity of mixed polyethyleneglycol modified liposomes containing doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Dendrimers and dendritic polymers in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

MMPs-specific PEGylated peptide-DOX conjugate micelles that can contain free doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Formulation and cytotoxicity of doxorubicin loaded in self-assembled bio-polyelectrolyte microshells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Fluorescence intensity and lifetime imaging of free and micellar-encapsulated doxorubicin in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Biodistribution of doxorubicin-alkylated poly(L-lysine citramide imide) conjugates in an experimental model of peritoneal carcinomatosis after intraperitoneal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation: effect of polymer chain modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Injectable in situ forming drug delivery system for cancer chemotherapy using a novel tissue adhesive: characterization and in vitro evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Antitumor effect of an injectable in-situ forming drug delivery system composed of a novel tissue adhesive containing doxorubicin hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Cardiotoxicity and anthracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Doxorubicin-encapsulated thermosensitive liposomes modified with poly(N-isopropylacrylamide-co-acrylamide): Drug release behavior and stability in the presence of serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Complexation and release of doxorubicin from its complexes with pluronic P85-b-poly(acrylic acid) block copolymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

Protective effect of N-acetylcysteine, caffeic acid and vitamin E on doxorubicin hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700611

10.1177/153303460800700611

21 January 2018

Identifiers

DOI

1 reference

release_oq2iqinppnf3jm2gxufteguuzm

19 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oq2iqinppnf3jm2gxufteguuzm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference